Abbott Gains CE Marks For New Tricuspid Device And Expanded Xience DES Indication

The next-generation TriClip G4 comes in more sizes than the original TriClip and features enhanced leaflet grasping features.

Triclip transcatheter tricuspid repair device
TriClip G4 Transcatheter Tricuspid Repair Clip • Source: Abbott

Abbott announced two important CE marks, expanding access to the company’s TriClip minimally invasive tricuspid valve repair technology and its market-leading Xience everolimus-eluting coronary stent.

On 8 April, Abbott announced it received a CE mark for the TriClip G4, the next-generation version of its TriClip...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Approvals

More from Policy & Regulation